Viewing Study NCT04220892

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:43 PM
Ignite Modification Date: 2026-04-05 @ 1:10 AM
Study NCT ID: NCT04220892
Status: WITHDRAWN
Last Update Posted: 2020-07-31
First Post: 2019-11-26
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High Grade Glioma
Sponsor: Jose Carrillo
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None High Grade Glioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Immunotherapy View
None Pembrolizumab View
None Pemetrexed View
None Abemaciclib View
None Cyclin-dependent kinase 4 (CDK4) View
None Cyclin-dependent kinase 6 (CDK6) View
None Folate antimetabolite View